Repeat HIV testing of individuals with discrepant HIV self-test results in Central Uganda.

According to the user instructions from the manufacturer of OraQuick HIV self-test (HIVST) kits, individuals whose kits show one red band should be considered to be HIV-negative, no matter how weak the band is.

However, recent reports show potential for a second false weak band after storage, thereby creating confusion in the interpretation of results. In this study, we re-tested individuals whose results were initially non-reactive but changed to weak reactive results to determine their true HIV status.

This study was nested within a large, cluster-randomized HIVST trial implemented among pregnant women attending antenatal care and their male partners in central Uganda between July 2016 and February 2017. Ninety-five initially HIV-negative respondents were enrolled into this study, including 52 whose kits developed a second weak band while in storage and 43 whose kits were interpreted as HIV-positive by interviewers at the next follow-up interview.

Respondents were invited to return for repeat HIVST which was performed under the observation of a trained nurse counsellor. After HIVST, respondents underwent blood-based rapid HIV testing as per the national HIV testing algorithm (Determine (Abbot Laboratories), STAT-PAK (Chembio Diagnostic Systems Inc.) and Unigold (Trinity Biotech plc.) and dry blood spots were obtained for DNA/PCR testing. DNA/PCR was considered as the gold-standard HIV testing method.

PEG5-Ms
573027 500.0mg
EUR 360

PEG4-Ms
HY-140388 Get quote Ask for price
Description: PEG4-Ms is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

PEG4-Ms
T16459-10mg 10mg Ask for price
Description: PEG4-Ms

PEG4-Ms
T16459-1g 1g Ask for price
Description: PEG4-Ms

PEG4-Ms
T16459-1mg 1mg Ask for price
Description: PEG4-Ms

PEG4-Ms
T16459-50mg 50mg Ask for price
Description: PEG4-Ms

PEG4-Ms
T16459-5mg 5mg Ask for price
Description: PEG4-Ms

PEG-MGF
A002-02 2 mg Ask for price

4-Arm PEG-MA
abx085177-10kDa1g 10 kDa; 1 g
EUR 610.8

4-Arm PEG-MA
abx085177-20kDa1g 20 kDa; 1 g
EUR 610.8

4-Arm PEG-MA
abx085177-20kDa5g 20 kDa; 5 g
EUR 1228.8

4-Arm PEG-MA
abx085177-5kDa1g 5 kDa; 1 g
EUR 577.2

N-(m-PEG4)-N'-(PEG3-Mal)-Cy5
HY-141076 Get quote Ask for price
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

N-(m-PEG4)-N'-(PEG3-Mal)-Cy5
T18435-10mg 10mg Ask for price
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5

N-(m-PEG4)-N'-(PEG3-Mal)-Cy5
T18435-1g 1g Ask for price
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5

N-(m-PEG4)-N'-(PEG3-Mal)-Cy5
T18435-1mg 1mg Ask for price
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5

N-(m-PEG4)-N'-(PEG3-Mal)-Cy5
T18435-50mg 50mg Ask for price
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5

N-(m-PEG4)-N'-(PEG3-Mal)-Cy5
T18435-5mg 5mg Ask for price
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5

4-Arm PEG-Mal
abx085089-100l 100 µl
EUR 300

4-Arm PEG-Mal
abx085089-10kDa1g 10 kDa; 1 g
EUR 477.6

4-Arm PEG-Mal
abx085089-1ml 1 ml
EUR 312.5

4-Arm PEG-Mal
abx085089-200l 200 µl
EUR 312.5

4-Arm PEG-Mal
abx085089-20kDa1g 20 kDa; 1 g
EUR 477.6

4-Arm PEG-Mal
abx085089-20kDa5g 20 kDa; 5 g
EUR 844.8

4-Arm PEG-Mal
abx085089-5kDa1g 5 kDa; 1 g
EUR 444

8-Arm PEG-Mal
abx085119-100l 100 µl
EUR 300

8-Arm PEG-Mal
abx085119-10kDa1g 10 kDa; 1 g
EUR 444

8-Arm PEG-Mal
abx085119-1ml 1 ml
EUR 300

8-Arm PEG-Mal
abx085119-200l 200 µl
EUR 300

8-Arm PEG-Mal
abx085119-20kDa1g 20 kDa; 1 g
EUR 444

8-Arm PEG-Mal
abx085119-20kDa5g 20 kDa; 5 g
EUR 961.2

8-Arm PEG-Mal
abx085119-40kDa1g 40 kDa; 1 g
EUR 444

Cy3.5-PEG-Mal
abx085322-100l 100 µl
EUR 662.5

Cy3.5-PEG-Mal
abx085322-10kDa500mg 10 kDa; 500 mg
EUR 961.2

Cy3.5-PEG-Mal
abx085322-1ml 1 ml
EUR 662.5

Cy3.5-PEG-Mal
abx085322-200l 200 µl
EUR 662.5

Cy3.5-PEG-Mal
abx085322-2kDa500mg 2 kDa; 500 mg
EUR 961.2

Cy3.5-PEG-Mal
abx085322-34kDa500mg 3.4 kDa; 500 mg
EUR 961.2

Cy3.5-PEG-Mal
abx085322-5kDa500mg 5 kDa; 500 mg
EUR 961.2

PCL(12K)-PEG-Mal
abx085326-10kDa500mg 10 kDa; 500 mg
EUR 1144.8

PCL(12K)-PEG-Mal
abx085326-2kDa500mg 2 kDa; 500 mg
EUR 1144.8

PCL(12K)-PEG-Mal
abx085326-5kDa500mg 5 kDa; 500 mg
EUR 1144.8

PLGA(5K)-PEG-Mal
abx085332-34kDa500mg 3.4 kDa; 500 mg
EUR 1245.6

PLGA(50:50)(8K)-PEG-Mal
abx085344-05kDa500mg 0.5 kDa; 500 mg
EUR 1296

PLGA(50:50)(8K)-PEG-Mal
abx085344-1kDa500mg 1 kDa; 500 mg
EUR 1446

PLGA(50:50)(8K)-PEG-Mal
abx085344-2kDa500mg 2 kDa; 500 mg
EUR 1479.6

PLGA(50:50)(8K)-PEG-Mal
abx085344-34kDa500mg 3.4 kDa; 500 mg
EUR 1479.6

PCL(12K)-PEG-Mal,2K
HE062022-2K-500mg 500mg
EUR 800.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PCL(12K)-PEG-Mal,5K
HE062022-5K-500mg 500mg
EUR 800.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(5K)-PEG-MAL,2K
HE085022-2K-500mg 500mg
EUR 873.6
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(5K)-PEG-MAL,3.4K
HE085022-3.4K-500mg 500mg
EUR 873.6
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(5K)-PEG-MAL,5K
HE085022-5K-500mg 500mg
EUR 873.6
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(50:50)?8K?-PEG-Mal,1K
HE086022-1K-500mg 500mg
EUR 800.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(50:50)?8K?-PEG-Mal,2K
HE086022-2K-500mg 500mg
EUR 770.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(50:50)?8K?-PEG-Mal,3.4K
HE086022-3.4K-500mg 500mg
EUR 770.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(50:50)?8K?-PEG-Mal,500
HE086022-500-500mg 500mg
EUR 918
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(50:50)?8K?-PEG-Mal,5K
HE086022-5K-500mg 500mg
EUR 770.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Cy3.5-PEG-Mal,2K
FL077022-2K-500mg 500mg
EUR 652.8
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Cy3.5-PEG-Mal,3.4K
FL077022-3.4K-500mg 500mg
EUR 652.8
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Cy3.5-PEG-Mal,5K
FL077022-5K-500mg 500mg
EUR 652.8
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(30K)-PEG-Mal
abx085340-100l 100 µl
EUR 625

PLGA(30K)-PEG-Mal
abx085340-1ml 1 ml Ask for price

PLGA(30K)-PEG-Mal
abx085340-200l 200 µl
EUR 1025

PCL(12K)-PEG-Mal,10K
HE062022-10K-500mg 500mg
EUR 800.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PCL(12K)-PEG-Mal,20K
HE062022-20K-500mg 500mg
EUR 800.4
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(12K)-PEG-MAL,2K
33-HE088022-2K
  • Ask for price
  • Ask for price
  • 100MG
  • 500MG
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(12K)-PEG-MAL,3.4K
33-HE088022-3.4K
  • Ask for price
  • Ask for price
  • 100MG
  • 500MG
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(12K)-PEG-MAL,5K
33-HE088022-5K
  • Ask for price
  • Ask for price
  • 100MG
  • 500MG
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

PLGA(18K)-PEG-MAL,3.4K
33-HE118022-3.4K
  • Ask for price
  • Ask for price
  • 100mg
  • 500mg
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Cy3.5-PEG-Mal,10K
FL077022-10K-500mg 500mg
EUR 652.8
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Cy3.5-PEG-Mal,20K
FL077022-20K-500mg 500mg
EUR 652.8
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Anti MGF PEG-MGF Pab
165657 100 µg Ask for price

PEG3-methylamine
HY-140161 100 mg
EUR 54.11
Description: PEG3-methylamine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

PEG3-methylamine
T16457-10mg 10mg Ask for price
Description: PEG3-methylamine

PEG3-methylamine
T16457-1g 1g Ask for price
Description: PEG3-methylamine

PEG3-methylamine
T16457-1mg 1mg Ask for price
Description: PEG3-methylamine

PEG3-methylamine
T16457-50mg 50mg Ask for price
Description: PEG3-methylamine

PEG3-methylamine
T16457-5mg 5mg Ask for price
Description: PEG3-methylamine

PEG8000-MgCl2 Solution (40%, Sterilized)
G0562
  • Ask for price
  • Ask for price
  • 100 mL
  • 500 mL

Anti-TACSTD2 (clone 7E6)-PEG6-MMAD ADC
ADC-W-292 1mg Ask for price
Description: This ADC product is comprised of an anti-TACSTD2 monoclonal antibody (clone 7E6) conjugated via a PEG6 linker to MMAD

Anti-TACSTD2 (clone C16)-PEG6-MMAD ADC
ADC-W-538 1mg Ask for price
Description: This ADC product is comprised of an anti-TACSTD2 monoclonal antibody (clone C16) conjugated via a PEG6 linker to MMAD

4-Arm PEG-Methacrylate
abx085177-100l 100 µl
EUR 362.5

4-Arm PEG-Methacrylate
abx085177-1ml 1 ml
EUR 362.5

4-Arm PEG-Methacrylate
abx085177-200l 200 µl
EUR 362.5

Anti-MUC1 (clone huC242)-PEG4Mal-DM1 ADC
ADC-W-313 1mg Ask for price
Description: This ADC product is comprised of an anti-MUC1 monoclonal antibody (clone huC242) conjugated via a PEG4Mal linker to a DM1

Anti-TNFRSF17 (clone 2A1)-PEG4-Mal-DM4 ADC
ADC-W-121 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF17 monoclonal antibody (clone 2A1) conjugated via a PEG4-Mal linker to DM4

Anti-TNFRSF17 (clone 1E1)-PEG4-Mal-DM4 ADC
ADC-W-125 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF17 monoclonal antibody (clone 1E1) conjugated via a PEG4-Mal linker to DM4

16.67% PEG / 3.33M NaCl solution
IBS-BP073 1L
EUR 56

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)
HY-140095 100 mg
EUR 216.45
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)
T16248-10mg 10mg Ask for price
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)
T16248-1g 1g Ask for price
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)
T16248-1mg 1mg Ask for price
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)
T16248-50mg 50mg Ask for price
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)
T16248-5mg 5mg Ask for price
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester)

PEG-modified Au Nanorods (Absorption Peak 690-850 nm)
NM005020 10 mL Ask for price

Polyethylene glycol monomethacrylate (PEGMA 440)
24890-100 100g
EUR 71.28
Description: 25736-86-1

Polyethylene glycol monomethacrylate (PEGMA 440)
24890-1000 1kg
EUR 396.36
Description: 25736-86-1

Polyethylene glycol monomethacrylate (PEGMA 200)
16712-100 100g
EUR 86.4
Description: 25736-86-1

Polyethylene glycol monomethacrylate (PEGMA 400)
16713-100 100g
EUR 75.6
Description: 25736-86-1

AzoDye-3 PEG10 Azide
2483-1mg 1 mg
EUR 148
Description: AzoDye-3 PEG 10 azide is an excellent building block for labeling alkyne-containing molecules.

AzoDye-3 PEG10 Alkyne
2485-1mg 1 mg
EUR 148
Description: AzoDye-3 PEG10 alkyne is an excellent building block for labeling azide-containing molecules.

PEG3 (untagged)-Human paternally expressed 3 (PEG3) transcript variant 3
SC327712 10 µg Ask for price

Boc-Gly-amido-(CH2)3-PEG3-(CH2)3-amine
571879 100.0mg
EUR 460

PEG3 (GFP-tagged) - Human paternally expressed 3 (PEG3), transcript variant 3
RG229077 10 µg Ask for price

PEG3 (Myc-DDK-tagged)-Human paternally expressed 3 (PEG3), transcript variant 3
RC229077 10 µg Ask for price

JBScreen Classic 3 (PEG 4000+ based)
M-CS-103L 24 solutions
EUR 249
Description: JBScreen Classic 3 (PEG 4000+ based)

Peg10 3'UTR GFP Stable Cell Line
TU266070 1.0 ml Ask for price

Peg12 3'UTR GFP Stable Cell Line
TU266071 1.0 ml Ask for price

Peg10 3'UTR GFP Stable Cell Line
TU166183 1.0 ml Ask for price

Peg12 3'UTR GFP Stable Cell Line
TU166184 1.0 ml Ask for price

PEG10 3'UTR GFP Stable Cell Line
TU067724 1.0 ml
EUR 5540.4

pEGFP-C1-3
PVT27074 2ug
EUR 280

Olivetolic Acid PEG2/3-Biotin
O533015 50mg
EUR 25000

Olivetolic Acid PEG2/3-Biotin
TRC-O533015-50MG 50 mg Ask for price

pEGFP-3-NLS
PVT14641 2 ug
EUR 843.6

PEG10 3'UTR Luciferase Stable Cell Line
TU017724 1.0 ml
EUR 5540.4

Peg10 3'UTR Luciferase Stable Cell Line
TU116183 1.0 ml Ask for price

Peg12 3'UTR Luciferase Stable Cell Line
TU116184 1.0 ml Ask for price

Peg10 3'UTR Luciferase Stable Cell Line
TU216070 1.0 ml Ask for price

Peg12 3'UTR Luciferase Stable Cell Line
TU216071 1.0 ml Ask for price

Paternally Expressed 3 (PEG3) Antibody
20-abx013786
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 100 ug
  • 200 ug
  • 300 µg

Paternally Expressed 3 (PEG3) Antibody
20-abx323448
  • Ask for price
  • Ask for price
  • 50 ug
  • 100 ug

Paternally Expressed 3 (PEG3) Antibody
abx331093-100ul 100 ul
EUR 510

DOTA-(t-Butyl)3-PEG5-azide
572295 5.0mg
EUR 630

DOTA-(t-butyl)3-PEG5-azide
HY-140753 Get quote Ask for price
Description: DOTA-(t-butyl)3-PEG5-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. DOTA-(t-butyl)3-PEG5-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

DOTA-(t-butyl)3-PEG5-azide
T17846-10mg 10mg Ask for price
Description: DOTA-(t-butyl)3-PEG5-azide

DOTA-(t-butyl)3-PEG5-azide
T17846-1g 1g Ask for price
Description: DOTA-(t-butyl)3-PEG5-azide

DOTA-(t-butyl)3-PEG5-azide
T17846-1mg 1mg Ask for price
Description: DOTA-(t-butyl)3-PEG5-azide

DOTA-(t-butyl)3-PEG5-azide
T17846-50mg 50mg Ask for price
Description: DOTA-(t-butyl)3-PEG5-azide

DOTA-(t-butyl)3-PEG5-azide
T17846-5mg 5mg Ask for price
Description: DOTA-(t-butyl)3-PEG5-azide

Peg12 sgRNA CRISPR Lentivector (Rat) (Target 3)
K6370804 1.0 ug DNA
EUR 184.8

Peg3 (untagged) - Mouse paternally expressed 3 (Peg3), (10ug)
MC224695 10 µg Ask for price

PEG10 sgRNA CRISPR Lentivector (Human) (Target 3)
K1626704 1.0 ug DNA
EUR 184.8

Peg12 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K3769504 1.0 ug DNA
EUR 184.8

Peg10 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K4676404 1.0 ug DNA
EUR 184.8

Peg3 3'UTR GFP Stable Cell Line
TU166185 1.0 ml Ask for price

PEG3 3'UTR GFP Stable Cell Line
TU067722 1.0 ml
EUR 2799.6

pEGFP- STAG2- 3* FLAG
PVT11615 2 ug
EUR 452.4

FRAT 3 (Frequently Rearranged in Advanced T-cell Lymphomas 3, Peg12, Paternally Expressed 12)
MBS622869-01mg 0.1mg
EUR 520

FRAT 3 (Frequently Rearranged in Advanced T-cell Lymphomas 3, Peg12, Paternally Expressed 12)
MBS622869-5x01mg 5x0.1mg
EUR 2185

JBScreen PEG/Salt 3
CS-143 24solutions
EUR 198.63

JBScreen PEG/Salt 3
M-CS-143 24 solutions
EUR 263
Description: JBScreen PEG/Salt 3

Absolute Mag™ PEG300 Magnetic Polystyrene Particles, 3 μm
WHM-G394 10 ml
EUR 928

PEG3 3'UTR Luciferase Stable Cell Line
TU017722 1.0 ml
EUR 2799.6

Peg3 3'UTR Luciferase Stable Cell Line
TU116185 1.0 ml Ask for price

3-D Life PEG-Link
L50-1 200 µl
EUR 41.8

3-D Life PEG-Link
L50-3 3x 200 µl
EUR 91.3

PEG3 sgRNA CRISPR Lentivector (Human) (Target 3)
K1626504 1.0 ug DNA
EUR 184.8

Peg3 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K4341804 1.0 ug DNA
EUR 184.8

PEG3 (untagged)-Human paternally expressed 3 (PEG3), transcript variant 1
SC128281 10 µg Ask for price

After repeat HIVST, 90 (94.7%) tested HIV-negative; 2 (2.1%) tested HIV-positive; and 3 (3.2%) had missing HIV test results. When respondents were subjected to blood-based rapid HIV testing, 97.9% (93/95) tested HIV-negative while 2.1% (2/95) tested HIV-positive.